Skip to content

Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation

Z 32503 - Prospective Evaluation of an AI Diagnostic Ultrasound Tool for Fetal Weight Estimation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07661433
Enrollment
1000
Registered
2026-06-22
Start date
2026-06-29
Completion date
2026-12-01
Last updated
2026-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Weight, Machine Learning, Pregnancy, Pregnancy - Prenatal Testing

Brief summary

Purpose: The primary objective of this study is to assess the diagnostic accuracy of an AI-enabled ultrasound tool for estimating fetal weight Participants: 1,000 pregnant individuals Procedures (methods): This prospective diagnostic accuracy study will enroll 1,000 pregnant individuals within one week of anticipated delivery. At a single visit, each participant will undergo two ultrasound assessments: (1) standardized sweeps for AI analysis (performed by both specialist and nonspecialist users), (2) specialist-performed fetal biometry.

Interventions

DIAGNOSTIC_TESTAI ultrasound diagnostic tool for fetal weight estimation

Participants will undergo study-specific transabdominal ultrasound acquisition using standardized abdominal sweeps of the gravid abdomen, guided by external maternal landmarks and saved as cineloop videos. The cineloop videos will be analyzed by a locked deep-learning AI diagnostic tool to generate an estimated fetal weight. The AI-generated estimate will be compared with specialist-performed fetal biometry and actual birth weight to evaluate diagnostic accuracy. The AI output is for research evaluation only and will not direct clinical management during the study.

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER
Bill and Melinda Gates Foundation
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Viable intrauterine pregnancy * Delivery expected within one week of study procedures between 24 0/7 and 42 6/7 weeks, including participants with a scheduled induction or cesarean delivery on a known date, or those admitted in spontaneous labor * Ability and willingness to provide written informed consent * Willingness to comply with all study procedures

Exclusion criteria

* Maternal body mass index ≥ 40 kg/m\^2 * Multiple gestation (i.e., twins or higher order) * Known major fetal malformation or anomaly * Any maternal condition (medical, psychological, or social) that, in the opinion of the study team, may interfere with study participation or data integrity.

Design outcomes

Primary

MeasureTime frameDescription
Difference in Mean Absolute Percent Error (MAPE) in fetal weight estimationWithin 1 week of delivery, 24-42 weeks of gestationMean of pairwise differences in absolute percent error between the AI diagnostic tool (index test) and specialist biometry (clinical reference standard), compared against actual birthweight (ground truth).

Secondary

MeasureTime frameDescription
Proportion of fetal weight estimates within 10% of actual birthweightWithin 1 week of delivery, 24-42 weeks of gestationBetween-method difference in the proportion of estimates within 10% of actual birthweight (ground truth) for the AI diagnostic tool (index test) versus specialist biometry (clinical reference standard).

Countries

Canada, Rwanda, United States, Zambia

Contacts

CONTACTJeffrey R Stringer, MD
jeff_stringer@unc.edu919-962-4717
PRINCIPAL_INVESTIGATORJeffrey Stringer, MD

University of North Carolina, Chapel Hill

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 9, 2026